MICROPLAITE

Medical devices have to undergo a large number of tests before they can be marketed, including in vivo tests on animals. The challenge addressed by this project is to reduce the number of in vivo tests by developing an innovative microfluidic platform for the evaluation of tissue reconstruction medical devices. This “organ-on-a-chip” approach is a real technological breakthrough and an extremely useful innovation with the aim of not only reducing the use of animals for the validation of this type of device, but also making this type of therapeutic approach much more accessible to the widest possible audience.
The GEMTEX laboratory will contribute to the MICROPLAITE project by producing new supports for tissue reconstruction. Not only cell growth, but also the study of their biocompatibility, as well as various properties they might have, such as antimicrobial properties, are aspects studied for the design of structures on all scales. (Polymers, yarns, knitted contexts). The structures will act as scaffolds for tissue regeneration, and will be tested using microfluidic platforms set up by SIRRIS.